Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Sun Pharmas Future GLP-1 Pipeline Apart from generics, Sun Pharma is also working on innovative obesity drugs such as: Utreglutide (GL0034) an experimental drug showing promising weight loss results in clinical trials This indicates the companys long-term strategy: Not just generics, but innovation-led growth in global markets like the U.S
Enhanced blood sugar control in type 2 diabetes, via both incretin pathways
Belching and gastrointestinal symptoms with Ozempic are typically transient, occurring mainly during dose escalation
The pharmacokinetics of most victim drugs were not affected by GLP-1 RAs
US$ 22.10
US$ 24.06
US$ 28.93
US$ 29.80
US$ 22.37
US$ 28.51
